
Sabrina Absalon
Indiana University School of Medicine
USA
EMBL Conference
This conference will take place at EMBL Heidelberg, with the option to attend virtually.
Registration is not yet open for this event. If you are interested in receiving more information please register your interest.
Malaria remains one of the most significant global public health challenges, with more than 200 million clinical cases worldwide each year. The lack of a vaccine that provides effective long-term protection and the continual emergence of drug-resistant malaria parasites emphasises the need for new control and prevention strategies.
This need for innovation has become even more apparent with the disruption of global malaria control programs due to the COVID-19 pandemic and potential reversal of gains made over the last few decades, highlighted through a marked increase in malaria deaths in recent years.
The generation of fundamental knowledge lies at the heart of developing new tools and innovations for malaria intervention. The malaria research community has a long history of being a highly collaborative field, reliant on diverse technologies, sharing of resources and dissemination of biological advances made. Now more than ever it is important that we take advantage of the full diversity of the malaria scientific community to share the advances of cross-disciplinary work that are vital for the translation of new ideas into public health impact.
“BioMalPar 2023 encompassed a spectacular range of research spanning basic to translational. The program content was topical and comprehensive, and the overall event was well-organized to achieve a dynamic environment that fuelled great discussions and networking.” – Jacquin Niles, Massachusetts Institute of Technology, USA
“Participating in Biomalpar XIX has been a great opportunity for a 1st year PhD like me, fresh in malaria field, to see an overall of the research activities and opportunities in that field. I am so grateful that I have met such great and talented scientists in that field.” – Geoff McFadden, MIVEGEC-IRD, France
“After a decade working on malaria research, I had heard high opinions of BioMalPar. However, this was my first time attending and clearly exceeded my expectations. Excellent scientific content with a balanced blend of senior and junior scientists. Smoothly organised in a venue that favours networking organically.” – Sarah Auburn, Institute of Cell Biology, University of Bern, Switzerland
Indiana University School of Medicine
USA
Institut Pasteur
France
Ifakara Health Institute
Tanzania
Sponsorship opportunities
We offer a variety of event sponsoring possibilities, with the flexibility to select a set sponsorship package or combine individual sponsorship options to suit your event budget. Discounts are available for companies sponsoring multiple events at EMBL Heidelberg. View other conferences, or contact sponsorship@embl.de for further information on sponsoring possibilities.
If you are interested in becoming a media partner of this event, please visit our media partnerships webpage.
EMBL wishes to warn sponsors of EMBL conferences and courses of fraudulent schemes purporting to offer sponsorship opportunities on behalf of EMBL or affiliated with EMBL officials. One current scam campaign of which we are aware is conducted using the name ‘Judy Eastman’ (judy@gopcontact.a2hosted.com) and entails approaches to sponsors offering sponsorship opportunities on EMBL’s behalf. Please be kindly advised that all relevant communication regarding sponsorship of EMBL conferences, symposia and courses is handled by EMBL directly and is sent from an official EMBL account. EMBL does not work with any external providers on sponsorship acquisition.
Please also note that:
Suspicious communications purportedly from, for or on behalf of EMBL should be reported to EMBL at the following email address sponsorship@embl.de.
Date: 21 - 23 May 2024
Location: EMBL Heidelberg and Virtual
Venue: EMBL Advanced Training Centre
Organisers:
Contact: Diah Yulianti
EMBL Courses and Conferences are kindly supported by our Corporate Partnership Programme